Our prescriber will carry out a thorough clinical assessment and may ask clarifying questions based on your answers
This substantial difference stems from their fundamentally different mechanisms-Zepbound is a dual GIP and GLP-1 receptor agonist, while Trulicity operates solely as a GLP-1 receptor agonist
Thyroid Cancer: Similar to other GLP-1 drugs, exenatide may have a potential risk for thyroid cancer (particularly medullary thyroid carcinoma), though this has not been definitively proven in humans
Those qualifying conditions include type 2 diabetes, hypertension, high cholesterol, obstructive sleep apnea, cardiovascular disease, polycystic ovary syndrome, and non-alcoholic fatty liver disease
Keeping up with the Joneses mentality creates comparison pressures that intensify weight struggles beyond simple biological challenges
Step 4: Hold and count